Group leader, Principal Investigator, PhD
Peter Horvath is currently a group leader at FIMM as well as group leader and a director of Institute of Biochemistry at the Biological Research Center of the Hungarian Academia of Sciences in Szeged. He hold a Tekes/Business Finland Finnish Distinguished Professor (FiDiPro) Fellow position at FIMM 2014-2018. He graduated as a software engineer and mathematician, and received his Ph.D. from INRIA and University of Nice, Sophia Antipois, France in satellite image analysis. Between 2007 and 2013 he was a senior scientist at the ETH Zurich, in the Light Microscopy Centre.
Peter Horvath is interested in solving computational cell biology problems related to light microscopy and is involved in three main research fields; 2/3D biological image segmentation and tracking; development of microscopic image correction techniques and machine learning methods applied in high-throughput microscopy.
Post-doctoral Researcher, Head of Unit, PhD
Antti Hassinen is the head of FIMM-HCA unit. He has previously worked in the Faculty of Biochemistry and Molecular Medicine in University of Oulu and gained his PhD in the group of Adj Prof Sakari Kellokumpu in 2013 working in the field of glycobiology and Golgi homeostasis in cancer cells. In the work he gained experience in molecular biology, cell biology, cytometry and microscopy techniques such as ratiometric pH measurements and image-based FRET as well as it’s applications in high throughput imaging.
His work in FIMM-HCA and the BIOMAG group is focused on providing open access high-throughput microscopy services to academic and commercial customers and collaborators and to apply in-house developed analysis tools into practice. One of the main research focuses is the development of 3D high-throughput microscopy and image analysis for use in drug sensitivity and resistance testing in close collaboration with the HTB FIMM unit.
Adjunct professor, PhD, Senior scientist
Vilja Pietiäinen is a senior scientist at the Institute for Molecular Medicine Finland (FIMM) and a team leader of personalized urological tumor project (DEDUCER) and ERAPerMed -funded project on clinical implementation of multidimensional phenotypical drug sensitivities in paediatric precision oncology (COMPASS).
Her research focuses on the systems medicine and precision therapeutics in cancer. She has M.Sc. in biochemistry and Ph.D. in virology/cell biology in 2005 (University of Edinburgh, U.K.; University of Helsinki-UH, Finland), and . Currently, she is particularly dedicated to develop high-content phenotypic image-based characterization and ex vivo drug testing of patient-derived cancer cell models.
Laboratory Coordinator, MSc
Involved in various single-cell related shenanigans. Recent focus in single-cell transcriptomics and morphology based cell recognition/isolation; utilizing high-content screening microscopy, image analysis, machine learning and laser microdissection microscopy.